Table 3.
Inflammatory markers at baseline and after the 8-week intervention in infertile polycystic ovary syndrome women candidate for in vitro fertilization that received either chromium supplements or placebo.
| Placebo group (n = 20) | Chromium group (n = 20) | Pa | |||||
|---|---|---|---|---|---|---|---|
| Baseline | End-of-trial | Change | Baseline | End-of-trial | Change | ||
| Hs-CRP (mg/L) | 5.7 ± 1.8 | 5.9 ± 2.6 | 0.2 ± 2.2 | 4.8 ± 2.6 | 3.4 ± 1.7 | −1.4 ± 1.5 | 0.01 |
| NO (μmol/L) | 41.8 ± 3.3 | 40.8 ± 4.2 | −1.0 ± 3.5 | 44.8 ± 8.7 | 45.0 ± 9.7 | 0.2 ± 3.1 | 0.24 |
Data are means ± SDs.
a
Obtained from repeated measures ANOVA test.
Hs-CRP, high-sensitivity C-reactive protein; NO, nitric oxide.